Wall Street Zen Upgrades Phreesia (NYSE:PHR) to Buy

Phreesia (NYSE:PHR) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday.

Other equities analysts also recently issued research reports about the company. KeyCorp cut their price objective on Phreesia from $15.00 to $12.00 and set an “overweight” rating for the company in a research report on Monday, April 13th. Piper Sandler downgraded Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 target price for the company. in a research report on Thursday. JPMorgan Chase & Co. restated a “neutral” rating and set a $16.00 target price (down from $24.00) on shares of Phreesia in a research report on Tuesday, March 31st. Needham & Company LLC dropped their target price on Phreesia from $35.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, March 31st. Finally, Mizuho dropped their target price on Phreesia from $22.00 to $19.00 and set an “outperform” rating for the company in a research report on Tuesday, March 24th. Nine investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Phreesia currently has an average rating of “Hold” and an average price target of $16.65.

Phreesia Trading Up 3.7%

Shares of PHR opened at $9.80 on Friday. The stock has a fifty day moving average price of $9.46 and a two-hundred day moving average price of $13.57. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.53 and a current ratio of 1.53. Phreesia has a 52-week low of $7.77 and a 52-week high of $32.76. The company has a market cap of $605.28 million, a price-to-earnings ratio of 65.33 and a beta of 0.89.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.03. Phreesia had a return on equity of 5.30% and a net margin of 1.85%.The firm had revenue of $130.94 million during the quarter, compared to the consensus estimate of $130.08 million. During the same quarter in the previous year, the company posted ($0.07) EPS. The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. Analysts predict that Phreesia will post 0.28 EPS for the current fiscal year.

Insider Transactions at Phreesia

In related news, insider Yvonne Hui sold 10,063 shares of Phreesia stock in a transaction on Thursday, April 16th. The stock was sold at an average price of $9.08, for a total transaction of $91,372.04. Following the completion of the sale, the insider directly owned 25,991 shares of the company’s stock, valued at $235,998.28. The trade was a 27.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Allison C. Hoffman sold 6,176 shares of Phreesia stock in a transaction on Monday, April 20th. The stock was sold at an average price of $9.06, for a total value of $55,954.56. Following the sale, the general counsel directly owned 157,309 shares of the company’s stock, valued at approximately $1,425,219.54. This trade represents a 3.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 50,493 shares of company stock worth $461,983. Insiders own 5.20% of the company’s stock.

Institutional Investors Weigh In On Phreesia

A number of institutional investors have recently made changes to their positions in the stock. Pale Fire Capital SE acquired a new stake in shares of Phreesia during the first quarter worth $72,481,000. Vanguard Group Inc. grew its stake in shares of Phreesia by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 5,744,326 shares of the company’s stock worth $97,194,000 after purchasing an additional 39,540 shares during the period. Greenhouse Funds LLLP grew its stake in shares of Phreesia by 16.8% during the third quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock worth $91,317,000 after purchasing an additional 557,265 shares during the period. Granahan Investment Management LLC grew its stake in shares of Phreesia by 73.8% during the fourth quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company’s stock worth $40,601,000 after purchasing an additional 1,018,987 shares during the period. Finally, Franklin Resources Inc. grew its stake in shares of Phreesia by 28.8% during the fourth quarter. Franklin Resources Inc. now owns 2,000,082 shares of the company’s stock worth $33,841,000 after purchasing an additional 446,890 shares during the period. 92.10% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Phreesia

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Phreesia reported fiscal Q1 2027 results that beat Wall Street expectations, with EPS of $0.05 versus $0.02 expected and revenue of $130.94 million above estimates; the company also cited 12.9% year-over-year revenue growth, which is helping sentiment. Article Title
• Positive Sentiment: The company also issued FY2027 revenue guidance of $510 million to $520 million, which is roughly in line with consensus and suggests management sees continued growth ahead. Article Title
• Positive Sentiment: Analysts reacted favorably overall, with DA Davidson reaffirming a Buy rating and Piper Sandler still seeing upside even after a downgrade to Neutral. Article Title
• Neutral Sentiment: Several law firms are publicizing a pending securities class action and a July 13, 2026 lead-plaintiff deadline for investors who bought Phreesia shares during the class period. These notices add headline risk, but they are procedural updates rather than new company operating news. Article Title
• Neutral Sentiment: Market coverage also noted that Phreesia shares rose after the earnings and revenue beat, reinforcing that the stock’s move is being driven mainly by the stronger-than-expected quarterly results. Article Title

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.